Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. Queensland was the source of 51% of prescriptions between 2016 and 2021.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Veriheal

JANUARY 26, 2023

A 2016 experiment conducted by scientists from Harvard Medical School, Tufts University, and McLean Hospital explored the impact of marijuana on both mood and cognitive function in those diagnosed with this mental health condition, making it the first such study ever undertaken in this area. The post Is Cannabis Good for Bipolar Disorder?

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

The Joint Blog

JANUARY 25, 2021

According to new research marijuana use is directly associated with a decrease in alcohol consumption among those seeking alcohol treatment. In particular, among individuals undergoing alcohol treatment, the impact of cannabis on alcohol intake may depend on cannabis use frequency. 18%-39%, p< 001) and were 2.06 times (95% C.I.

Treatment 26

Treatment Consumption Marijuana Data 26

Peninsula Alternative Health

MARCH 1, 2018

In 2016, Maryland contracted with ASA’s Patient Focused Certification program to train the officials tasked with watching over the state’s emerging medical cannabis program. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

In 2016, Maryland contracted with ASA’s Patient Focused Certification program to train the officials tasked with watching over the state’s emerging medical cannabis program. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

CannaMD

NOVEMBER 22, 2020

Unfortunately, most traditional pharmaceutical options are distinctly lacking due to side effects, as well as a bit of trepidation (although Botox, one current treatment option for migraines, has gained popularity). Patients used the app, Strainprint, which allowed data to be archived and studied. and migraine severity by 49.6%.

Marijuana 116

Marijuana Treatment Patients Cannabinoids 116

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Medicinal cannabis as a last resort.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

CannaMD

DECEMBER 8, 2020

Between 2016-2018, despite rapidly expanding state legalization, there was a slight increase in marijuana-related arrests year over year. In 2019, for example, FBI data shows 495,871 arrests made for violent crime – compared to the 500,395 individuals who were arrested for marijuana possession with no additional charges. Get Started.

Marijuana 105

Marijuana Chronic Pain Treatment Legalization 105

Cannabis Law Report

FEBRUARY 15, 2022

The goal is to use the data for comparative analysis over time to help shape state policy. The study uses a wealth of secondary data to provide a snapshot of present-day usage and law-enforcement measures across age, racial, and gender lines. NJSPL-Cannabis-Feb2022.

Policy 52

Policy Marijuana Data Education 52

Cannabis Law Report

MARCH 17, 2022

The national consumption of methylamphetamine, cocaine, MDMA and heroin increased year on year in the first four years of the Program (2016-17 to 2019-20), followed by a marked reduction in total consumption in year five (2020-21). The latest report presents data on Australia’s drug consumption for 12 substances. million Australians.

Consumption 52

Consumption Programs Data Treatment 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Research published in 2016 revealed that 59% of a sample of patients who misused opioids were first exposed to them through a medical prescription.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Chronicles

APRIL 3, 2019

I think the data is too new,” responded Schoening. Later in the session, Washington State Patrol Trooper Ben Taylor told the council that the data is still new and that marijuana legalization hasn’t created a huge increase in traffic fatalities. I tend to agree with you. Apples to buds to police calls. Violent crime.

Marijuana 100

Marijuana Data Recreational Topical 100

The Cannigma

JUNE 30, 2021

Medical marijuana came to the Ozarks after voters in Arkansas voted in favor of legalization in 2016, and the first medical dispensary opened in 2019. In its early days medical marijuana may have been mainly known as a treatment for glaucoma, cancer, or AIDS. Cancer 839 7.8%. PTSD 12,546 20.6% Severe arthritis 8,290 13.6%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

JANUARY 9, 2022

Oregon voters approved an initiative regulating cannabis for adult use in November 2014, and the state’s first adult-use stores opened in October 2016. In addition, the legislature allowed medical cannabis dispensaries to sell a limited amount of cannabis (five grams) to adults from October 2015 until December 31, 2016. 46,104,922.

Collective 52

Collective Policy Retail Programs 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] For the regulated community, this is a trend worth watching. Defining Psychedelics. 2] David E. 264, 266 (Apr. 4] Jennifer M.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Veriheal

JULY 5, 2021

Titled “ The Effectiveness of Common Cannabis Products for Treatment of Nausea ”, the newly published study indicates that most medical cannabis patients who endure nausea prefer to load up on THC, as opposed to CBD. The self-reported data was logged between June 6, 2016, and July 8, 2019. billion in legal U.S.

THC 52

THC CBD Treatment Cannabinoids 52

CannaMD

NOVEMBER 6, 2019

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4

Marijuana 88

Marijuana Patients Clinical Trials Data 88

Cannabis Law Report

JUNE 8, 2022

MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial. He previously served as the global CEO for both Sandoz and Alcon, at Novartis Group, where he served on the Executive Committee from 2008 to 2016.

Therapy 52

Therapy Treatment Access Patients 52

Cannabis Law Report

JANUARY 6, 2022

Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Insurance won’t cover treatment sessions due to psilocybin’s status as a Schedule I drug.

Access 52

Access Patients Research and Development Treatment 52

Canna Law Blog

DECEMBER 21, 2023

Sales fell (again) along with licensee numbers (for the first time) According to OLCC data , retail sales between January 1, 2023 and November 30, 2023 clocked in at $874 million. It’s not a big drop, but this was the first year I saw license numbers fall since the 2016 roll-out of the adult use program. That tally would be a 4.1%

Hemp 86

Hemp Retail Compliance Compliance 86

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In November of 2016, 71% of Florida voters approved the Florida Medical Marijuana Legalization Initiative (perhaps confusingly: also known as Amendment 2 ). .’

Law 126

Law Marijuana Patients Treatment 126

The Joint Blog

OCTOBER 6, 2019

For the study, researchers analyzed approximately 800,000 urine drug test results collected from pain management patients between the years 2016 and 2018. Further studies are also needed to determine if THC/cannabis use alone or in combination with other medical treatments may help combat OUD (opioid use disorder).”

Concentrates 48

Concentrates Patients THC Collective 48

Canabo Medical Clinic

NOVEMBER 29, 2018

Some studies suggest those using opioid medications can even reduce or eliminate their dependence on these substances by introducing medical marijuana to their treatment plans. The number of authorizations grew exponentially in 2016, and authorizations continued apace in 2017. More than 200,000 People Use Medical Cannabis.

Patients 40

Patients Data Conditions Cannabis 40

Cannabis Law Report

NOVEMBER 14, 2019

.” From November 2016 until August 2019, WA doctors issued 876 approvals to for medicinal cannabis prescriptions. The Department of Health reviewed three years of prescribing data in the lead-up to its decision. Full story at [link].

Patients 45

Patients Access Medicine Pharmaceutical 45

CannaMD

JUNE 18, 2020

Closer examination of the data revealed a number of important traits that influenced outcomes. In a 2016 assessment of the California and Minnesota studies, the authors noted: After adjustment for other substance use, these declines [in IQ] were substantially attenuated and no longer statistically significant. Find Out if You Qualify.

Research and Development 81

Research and Development Marijuana Education Treatment 81

Cannabis Law Report

JULY 28, 2021

Andy served as University of Alberta Associate Vice President (Research) and was a member of the Scientific Advisory Board of the CIHR Institute of Neuroscience Mental Health & Addiction from 2012-2016. “We would like to extend a warm welcome to Andy as he joins the team at Entheon. ” About Entheon Biomedical Corp.

Research and Development 105

Research and Development Events Media Data 105

Cannabis Law Report

FEBRUARY 17, 2020

Licensed Medical Marijuana Treatment Centers that are authorized to dispense medical marijuana products in a form for smoking or other delivery route to qualified patients include these fourteen companies called dispensaries : Trulieve. CANNABIS PRIMER. Glossary of Marijuana Terminologyvia CannaInsider.com. Americans for Safe Access.org.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

PrestoDoctor

SEPTEMBER 6, 2023

For example, a study published in the Journal of Pain in 2016 found that chronic pain patients who used medical cannabis reported a decrease in their opioid use and an improved quality of life. Individualized Treatment : Cannabis allows for a more personalized approach to pain management.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

NOVEMBER 18, 2019

We have sent some attorneys through our diversion program for professional substance abuse treatment. A Nevada Independent analysis of ownership data made public by the state indicates that there are at least 68 lawyers among the nearly 1,400 owners and board members who applied for or received recreational marijuana licenses in Nevada.

Dispensary 49

Dispensary Recreational Cannabis Marijuana 49

Freedom Leaf

OCTOBER 15, 2018

This move reinforced a federal ruling on April 16 that affirmed the December 2016 DEA decision to create a new Schedule I code for cannabis extracts, including CBD extracts. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives. percent in 2016. times more likely.

Marijuana 103

Marijuana Education Advocacy Legislation 103

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98